Suicidology as a social practice.

Suicide has long been the subject of philosophical, literary, theological, and cultural-historical inquiry. But despite the diversity of disciplinary and methodological approaches that have been brought to bear in the study of suicide, we argue that the formal study of suicide, that is, suicidology, is characterised by intellectual, organisational, and professional values that distinguish it from other ways of thinking and knowing. Further, we suggest that considering suicidology as a ‘social practice’ offers ways to usefully conceptualise its epistemological, philosophical, and practical norms. This work develops the idea of suicidology as a social practice and considers the implications for research, practice and public discourse. Keywords: Suicide, suicidology, social practice, ethicsn/

“‘Suicidology as a Social Practice': A Reply to Tom Widger.”

In recent years, a growing body of critical literature has emerged that challenges the dominant norms and practices of mainstream suicidological research. Concerns over epistemology and methodology, the (political) rationales that determine how suicide is researched and responded to, and the lack of measurable advances in knowledge and prevention, are, for a growing number of scholars, symptoms of a more widely felt paradigm crisis in contemporary suicide research. Tom Widger (2015) crystallises the incommensurability between the globalising paradigm of ‘scientific’ suicidology and the meanings and nuances of self-inflicted death in specific cultural contexts, extending the concerns raised by our article ‘Suicidology as a Social Practice’ (2014). While recent debates have largely focused on issues of methodological pluralism as a way of moving suicidology forward, Widger questions the degree by which any study of suicide can truly subvert the suicidological paradigm when it produces both the subject and object involved. As he says, the very concept of suicide is suicidological

A Small Interstellar Probe to the Heliospheric Boundary and Interstellar Space

The Small Interstellar Probe m1ss1on would be designed to cross the solar wind termination shock and the heliopause, and make a significant penetration into nearby interstellar space. The principal scientific objectives of this mission would be to explore the structure of the heliosphere, to investigate its interaction with the interstellar medium, and to explore the nature of the interstellar medium itself. These studies would be carried out by a ~200 kg spacecraft carrying a scientific payload designed to make comprehensive, in situ measurements of both heliospheric and interstellar plasma, fields, energetic particles, gas, and dust. New trajectory calculations indicate significantly improved performance over earlier studies with larger spacecraft, including spacecraft velocities ranging from -6 to -14 AU/yr., depending on trajectory and launch vehicle

Religious perspectives on the use of psychopharmaceuticals as an enhancement technology

The use of psychopharmaceuticals as an enhancement technology has been the focus of attention in the bioethics literature. However, there has been little examination of the challenges that this practice creates for religious traditions that place importance on questions of being, authenticity and identity. We asked expert commentators from six major world religions to consider the issues raised by psychopharmaceuticals as an enhancement technology. These commentaries reveal that in assessing the appropriate place of medical therapies, religious traditions, like secular perspectives, rely upon ideas about health and disease and about normal human behavior. But unlike secular perspectives, faith traditions explicitly concern themselves with ways in which medicine should or should not be used to live a ‘good life’. KEYWORDS: Enhancement; bioethics, psychopharmacology, religio

Religious perspectives on human suffering: Implications for medicine and bioethics

The prevention and relief of suffering has long been a core medical concern. But while this is a laudable goal, some question whether medicine can, or should, aim for a world without pain, sadness, anxiety, despair or uncertainty. To explore these issues, we invited experts from six of the world’s major faith traditions to address the following question. Is there value in suffering? And is something lost in the prevention and/or relief of suffering? While each of the perspectives provided maintains that suffering should be alleviated and that medicine’s proper role is to prevent and relieve suffering by ethical means, it is also apparent that questions regarding the meaning and value of suffering are beyond the realm of medicine. These perspectives suggest that medicine and bioethics has much to gain from respectful consideration of religious discourse surrounding suffering. Keywords Suffering; religion; medicine; bioethic

Religious perspectives on human suffering: Implications for medicine and bioethics

The prevention and relief of suffering has long been a core medical concern. But while this is a laudable goal, some question whether medicine can, or should, aim for a world without pain, sadness, anxiety, despair or uncertainty. To explore these issues, we invited experts from six of the world’s major faith traditions to address the following question. Is there value in suffering? And is something lost in the prevention and/or relief of suffering? While each of the perspectives provided maintains that suffering should be alleviated and that medicine’s proper role is to prevent and relieve suffering by ethical means, it is also apparent that questions regarding the meaning and value of suffering are beyond the realm of medicine. These perspectives suggest that medicine and bioethics has much to gain from respectful consideration of religious discourse surrounding suffering. Keywords Suffering; religion; medicine; bioethic

Search for boosted diphoton resonances in the 10 to 70 GeV mass range using 138 fb−1 of 13 TeV pp collisions with the ATLAS detector

A search for diphoton resonances in the mass range between 10 and 70 GeV with the ATLAS experiment at the Large Hadron Collider (LHC) is presented. The analysis is based on pp collision data corresponding to an integrated luminosity of 138 fb−1 at a centre-of-mass energy of 13 TeV recorded from 2015 to 2018. Previous searches for diphoton resonances at the LHC have explored masses down to 65 GeV, finding no evidence of new particles. This search exploits the particular kinematics of events with pairs of closely spaced photons reconstructed in the detector, allowing examination of invariant masses down to 10 GeV. The presented strategy covers a region previously unexplored at hadron colliders because of the experimental challenges of recording low-energy photons and estimating the backgrounds. No significant excess is observed and the reported limits provide the strongest bound on promptly decaying axion-like particles coupling to gluons and photons for masses between 10 and 70 GeV

Evidence for the charge asymmetry in pp → tt¯ production at s√ = 13 TeV with the ATLAS detector

Inclusive and differential measurements of the top–antitop (tt¯) charge asymmetry Att¯C and the leptonic asymmetry Aℓℓ¯C are presented in proton–proton collisions at s√ = 13 TeV recorded by the ATLAS experiment at the CERN Large Hadron Collider. The measurement uses the complete Run 2 dataset, corresponding to an integrated luminosity of 139 fb−1, combines data in the single-lepton and dilepton channels, and employs reconstruction techniques adapted to both the resolved and boosted topologies. A Bayesian unfolding procedure is performed to correct for detector resolution and acceptance effects. The combined inclusive tt¯ charge asymmetry is measured to be Att¯C = 0.0068 ± 0.0015, which differs from zero by 4.7 standard deviations. Differential measurements are performed as a function of the invariant mass, transverse momentum and longitudinal boost of the tt¯ system. Both the inclusive and differential measurements are found to be compatible with the Standard Model predictions, at next-to-next-to-leading order in quantum chromodynamics perturbation theory with next-to-leading-order electroweak corrections. The measurements are interpreted in the framework of the Standard Model effective field theory, placing competitive bounds on several Wilson coefficients

Search for heavy resonances decaying into a Z or W boson and a Higgs boson in final states with leptons and b-jets in 139 fb−1 of pp collisions at s√ = 13 TeV with the ATLAS detector

This article presents a search for new resonances decaying into a Z or W boson and a 125 GeV Higgs boson h, and it targets the νν¯¯¯bb¯¯, ℓ+ℓ−bb¯¯, or ℓ±νbb¯¯ final states, where ℓ = e or μ, in proton-proton collisions at s√ = 13 TeV. The data used correspond to a total integrated luminosity of 139 fb−1 collected by the ATLAS detector during Run 2 of the LHC at CERN. The search is conducted by examining the reconstructed invariant or transverse mass distributions of Zh or Wh candidates for evidence of a localised excess in the mass range from 220 GeV to 5 TeV. No significant excess is observed and 95% confidence-level upper limits between 1.3 pb and 0.3 fb are placed on the production cross section times branching fraction of neutral and charged spin-1 resonances and CP-odd scalar bosons. These limits are converted into constraints on the parameter space of the Heavy Vector Triplet model and the two-Higgs-doublet model